Phase 2Completed
A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.
A Double-Blind, 3-Arm Study on Weight Loss With a Combination of Micronised Fenofibrate 267 mg and Metformin 1,700 mg Per Day Compared to Metformin 1,700 mg and to Placebo, at 6 Months, in Obese Patients, Followed by: A Double-Blind, 2-Arm Investigation of Weight-Loss Maintenance With the Same Combination of Micronised Fenofibrate 267 mg and Metformin 1,700 mg Compared to Placebo, at 6 Months, in the Responders.
- Sponsor
- Solvay Pharmaceuticals (Industry)
- Enrollment
- 148 planned
- Conditions
- Obesity
- Interventions
- Metformin and Metformin + Fenofibrate
- Ages
- adults
- Registry
- NCT00349635, EUCTR2004-001731-28
Full record on ClinicalTrials.gov
From the registry
To investigate the effect on body weight of a combination fenofibrate and metformin on top of a moderate balanced calorie-deficit diet.
Primary outcomes
- Weight
History
Last registry update
Registered
Started